Few therapies are approved for the treatment of NAFLD. Now, researchers have shown that treatment with nicotinamide riboside, a precursor for NAD+ biosynthesis, can protect mice against the development of diet-induced NAFLD by increasing hepatic NAD+ levels. The treatment also reversed the disease in mice with pre-existing NAFLD. Nicotinamide riboside activated the hepatic mitochondrial unfolded protein response, increasing fatty acid oxidation and mitochondrial complex activity.
References
Gariani, K. et al. Eliciting the mitochondrial unfolded protein response via NAD+ repletion reverses fatty liver disease. Hepatology 10.1002/hep.28245
Rights and permissions
About this article
Cite this article
Boosting hepatic NAD+ prevents and reverses NAFLD in mice. Nat Rev Gastroenterol Hepatol 12, 608 (2015). https://doi.org/10.1038/nrgastro.2015.175
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.175